6.3.2.4 Insulins, rapid-acting
All insulins should be prescribed by brand
Please see Kent and Medway Guidance of Biosimilar Insulin Prescribing here.
Please see Kent and Medway Guidance on Safe Insulin Prescribing here.
*SUPPLY ISSUE: A Medicine Supply Notification (MSN) was issued on the 4th March 2024 on the shortage of Fiasp® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens. The shortage started on 1st April 2024, and on 26th November 2024 the anticipated resupply date has been updated to 2nd January 2026.
Please see the SPS medicines supply tool (free subscription required) for further information, actions and advice on alternatives and the current anticipated re-supply date.
Please do not initiate new patients on Fiasp® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens for the duration of the shortage.
NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens are being discontinued. Stock is anticipated to be exhausted by March 2025.
Please do not initiate new patients on NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens.
The recommendation in Kent and Medway is that patients currently prescribed NovoRapid® FlexTouch® pens are pro-actively reviewed and switched to Trurapi®, where clinically suitable in line with NICE guidelines on an individual patient basis.
Please see here on the SPS Medicines Supply Tool for more information and actions.
Expand All / Expand All (incl. cost)
Documents
-
Primary Care
-
Secondary Care
-
Primary and Secondary Care
East Kent Type 1 Diabetes Treatment Pathway EKPG recommendation, Sept 2018
Uploaded By:
Renewal: 09/2021
Approved: 09/2018
Last Reviewed: 09/2018
Caution: This document is due for renewal and may be out of date
Document linked to:
| Pack | Price |
|---|---|
| 1 vial | £16.00 |
| Pack | Price |
|---|---|
| 5 cartridge | £28.30 |
| Pack | Price |
|---|---|
| 5 pre-filled disposable injection | £28.30 |
| Pack | Price |
|---|---|
| 1 vial | £15.68 |
| Pack | Price |
|---|---|
| 5 cartridge | £19.08 |
Documents
-
Primary Care
-
Secondary Care
-
Primary and Secondary Care
East Kent Type 1 Diabetes Treatment Pathway EKPG recommendation, Sept 2018
Uploaded By:
Renewal: 09/2021
Approved: 09/2018
Last Reviewed: 09/2018
Caution: This document is due for renewal and may be out of date
Document linked to:
New patients should be started on Trurapi. Where clinically suitable in line with NICE guidelines on an individual patient basis, patients can be switched from originator product to Trurapi as a shared decision with a patient, with close glucose monitoring where this decision is made.
NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens are being discontinued. Stock is anticipated to be exhausted by March 2025.
Please do not initiate new patients on NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens.
The recommendation in Kent and Medway is that patients currently prescribed NovoRapid® FlexTouch® pens are pro-actively reviewed and switched to Trurapi®, where clinically suitable in line with NICE guidelines on an individual patient basis.
Please see here on the SPS Medicines Supply Tool for more information and actions.
| Pack | Price |
|---|---|
| 1 vial | £14.08 |
| Pack | Price |
|---|---|
| 5 pre-filled disposable injection | £30.60 |
| Pack | Price |
|---|---|
| 5 cartridge | £28.31 |
| Pack | Price |
|---|---|
| 5 cartridge | £15.10 |
| Pack | Price |
|---|---|
| 5 pre-filled disposable injection | £32.13 |
| Pack | Price |
|---|---|
| 1 vial | £11.97 |
| Pack | Price |
|---|---|
| 5 cartridge | £19.82 |
| Pack | Price |
|---|---|
| 5 pre-filled disposable injection | £21.42 |
Specialist initiation by consultant diabetologist, Diabetes Nurse Specialist or GP with Specialist Interest in Diabetes. This is used as an alternative second line to insulin aspart ‘Novorapid.’
| Pack | Price |
|---|---|
| 1 vial | £14.08 |
Specialist initiation by consultant diabetologist, Diabetes Nurse Specialist or GP with Specialist Interest in Diabetes. This is used as an alternative second line to insulin aspart ‘Novorapid.’
| Pack | Price |
|---|---|
| 5 pre-filled disposable injection | £30.60 |
Specialist initiation by consultant diabetologist, Diabetes Nurse Specialist or GP with Specialist Interest in Diabetes. This is used as an alternative second line to insulin aspart ‘Novorapid.’
| Pack | Price |
|---|---|
| 5 cartridge | £28.31 |
New patients should be started on Admelog. Where clinically suitable in line with NICE guidelines on an individual patient basis, patients can be switched from originator product to Admelog as a shared decision with a patient, with close glucose monitoring where this decision is made.
| Pack | Price |
|---|---|
| 1 vial | £14.12 |
| Pack | Price |
|---|---|
| 5 cartridge | £21.23 |
| Pack | Price |
|---|---|
| 5 pre-filled disposable injection | £22.10 |
| Pack | Price |
|---|---|
| 1 vial | £16.61 |
| Pack | Price |
|---|---|
| 5 cartridge | £28.31 |
| Pack | Price |
|---|---|
| 5 pre-filled disposable injection | £29.46 |
Lyumjev® is the second line option for the treatment of diabetes mellitus in adults who are suitable for Humalog® and their diabetes cannot be adequately managed with Humalog choices and at least one of the following applies:
- Where the prescriber believes a faster onset of action would be beneficial to the patient
- Where a patient requires ‘tight’ control of blood sugar levels
- Where a patient has rapid post-meal increase in blood sugar levels
Please note that there are two strengths of Lyumjev® available. Prescriptions should make the brand, strength, and device clear in line with MHRA guidance to avoid errors.
| Pack | Price |
|---|---|
| 1 vial | £16.61 |
Lyumjev® is the second line option for the treatment of diabetes mellitus in adults who are suitable for Humalog® and their diabetes cannot be adequately managed with Humalog choices and at least one of the following applies:
- Where the prescriber believes a faster onset of action would be beneficial to the patient
- Where a patient requires ‘tight’ control of blood sugar levels
- Where a patient has rapid post-meal increase in blood sugar levels
Please note that there are two strengths of Lyumjev® available. Prescriptions should make the brand, strength, and device clear in line with MHRA guidance to avoid errors.
| Pack | Price |
|---|---|
| 5 cartridge | £28.31 |
Lyumjev® is the second line option for the treatment of diabetes mellitus in adults who are suitable for Humalog® and their diabetes cannot be adequately managed with Humalog choices and at least one of the following applies:
- Where the prescriber believes a faster onset of action would be beneficial to the patient
- Where a patient requires ‘tight’ control of blood sugar levels
- Where a patient has rapid post-meal increase in blood sugar levels
Please note that there are two strengths of Lyumjev® available. Prescriptions should make the brand, strength, and device clear in line with MHRA guidance to avoid errors.
| Pack | Price |
|---|---|
| 5 pre-filled disposable injection | £29.46 |
Lyumjev® is the second line option for the treatment of diabetes mellitus in adults who are suitable for Humalog® and their diabetes cannot be adequately managed with Humalog choices and at least one of the following applies:
- Where the prescriber believes a faster onset of action would be beneficial to the patient
- Where a patient requires ‘tight’ control of blood sugar levels
- Where a patient has rapid post-meal increase in blood sugar levels
Please note that there are two strengths of Lyumjev® available. Prescriptions should make the brand, strength, and device clear in line with MHRA guidance to avoid errors.
| Pack | Price |
|---|---|
| 5 pre-filled disposable injection | £58.92 |
| Pack | Price |
|---|---|
| 5 pre-filled disposable injection | £29.46 |